Clinical trial
Prostate Immobilization Device Used During Radiation Treatments to Decrease…
NCT00114985 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00114985 |
|---|---|
| Title | Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding |
| Official title | A Phase II Study of Late Rectal Toxicity Following 3-D Conformal External Beam Radiation Therapy Performed Using a Prostate Immobilization Device |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Device |
| Interventions | Prostate Immobilization Device |
| Enrollment | 100 |
| Start date | Apr 1, 2001 |
| Primary completion | Jan 1, 2005 |
| Completion | Oct 1, 2008 |
| First posted | Jun 21, 2005 |
| Last update posted | May 3, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: